Whitehawk Therapeutics, Inc. (WHWK) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $02009: $11.1K2010: $26.9K2011: $4.1K2012: $4.6K2013: $6.3K2014: $5.3K2015: $5.14M2016: $1.61M2017: $20.26M2018: $62.61M2019: $38.52M2020: $4.46M2021: $148.99M2022: $39.02M2023: $62.89M2024: $28.67M2025: $37.57M$37.57M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$37.57M+31.0%
2024$28.67M-54.4%
2023$62.89M+61.2%
2022$39.02M-73.8%
2021$148.99M+3244.3%
2020$4.46M-88.4%
2019$38.52M-38.5%
2018$62.61M+209.0%
2017$20.26M+1158.9%
2016$1.61M-68.7%
2015$5.14M+97642.9%
2014$5.3K-16.2%
2013$6.3K+36.4%
2012$4.6K+11.7%
2011$4.1K-84.7%
2010$26.9K+141.4%
2009$11.1K
2007$0